During the past decade, Texas Transplant Institute conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 31 clinical trials were completed, i.e. on average, 119.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Transplant Institute" #1 sponsor was "Medical College of Wisconsin" with 15 trials, followed by "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials sponsored, "SCRI Development Innovations, LLC" with 4 trials sponsored, "Center for International Blood and Marrow Transplant Research" with 3 trials sponsored and "Genzyme, a Sanofi Company" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Transplant Institute" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 21 trials as a collaborator, "National Marrow Donor Program" with 18 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 17 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Texas Transplant Institute" are "Lymphoma" (9 trials), "Leukemia" (8 trials), "Myelodysplastic Syndromes" (8 trials), "Multiple Myeloma" (7 trials) and "Chronic Myelogenous Leukemia" (5 trials). Many other conditions were trialed in "Texas Transplant Institute" in a lesser frequency.

Most popular intervention types in "Texas Transplant Institute" are "Drug" (51 trials), "Biological" (19 trials), "Procedure" (10 trials), "Radiation" (8 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (9 trials), "Fludarabine" (8 trials), "Mycophenolate Mofetil" (5 trials), "Placebo" (5 trials) and "mycophenolate mofetil" (4 trials). Other intervention names were less common.

The vast majority of trials in "Texas Transplant Institute" are 67 trials for "All" genders.

Currently, there are NaN active trials in "Texas Transplant Institute". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Texas Transplant Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Transplant Institute, 13 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".

Texas Transplant Institute has several departments that took part in Clinical trials: "Methodist Children's Hospital of South Texas" - 184 trials, "Methodist Cancer Center at Methodist Specialty and Transplant Hospital" - 11 trials, "Blood Cancer and Stem Cell Transplant Clinic" - 2 trials